Results 51 to 60 of about 44,322 (189)

Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy

Frontiers in Pharmacology, 2023
Cardiomyopathies are a clinically heterogeneous group of cardiac diseases characterized by heart muscle damage, resulting in myocardium disorders, diminished cardiac function, heart failure, and even sudden cardiac death.
Huiyan Sun, Huiyan Sun, Dandan Chen, Wenjing Xin, Lixue Ren, Qiang LI, Xuchen Han   +6 more
doaj   +1 more source

Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies

Frontiers in Cardiovascular Medicine, 2022
ObjectiveNatural history of cardiac amyloidosis (CA) is poorly understood. We aimed to examine the changing mortality of different types of CA over a 30-year period.Patients and methodsConsecutive patients included in the “Trieste CA Registry” from ...
Aldostefano Porcari, Valentina Allegro, Riccardo Saro, Guerino Giuseppe Varrà, Linda Pagura, Maddalena Rossi, Andrea Lalario, Francesca Longo, Renata Korcova, Matteo Dal Ferro, Andrea Perkan, Franca Dore, Rossana Bussani, Giovanni Maria De Sabbata, Francesco Zaja, Francesco Zaja, Marco Merlo, Gianfranco Sinagra   +17 more
doaj   +1 more source

Cardiomyopathy and phaeochromocytoma [PDF]

Anaesthesia, 1983
Summary A ease is presented of phaeochromocytoma with catecholamine‐induced cardiomyopathy. The difficulties in the management when left ventricular failure occurred are reported and the importance of monitoring pulmonary artery pressure during the anaesthetic procedure is stressed.
F J, Gilsanz, C, Luengo, P, Conejero, P, Peral, F, Avello   +4 more
openaire   +2 more sources

Cardiomyopathies

, 2013
The disease of the heart muscle may occur secondarily to common diseases, such as ischemic, hypertensive and valvular, among others. However, there is a group of conditions with intrinsic myocardial involvement from gene or multifactorial etiology, and ...

core   +1 more source

Non-familial cardiomyopathies in Lebanon: exome sequencing results for five idiopathic cases

BMC Medical Genomics, 2019
Background Cardiomyopathies affect more than 0.5% of the general population. They are associated with high risk of sudden cardiac death, which can result from either heart failure or electrical abnormalities.
Marwan M. Refaat, Sylvana Hassanieh, Jad A. Ballout, Patrick Zakka, Mostafa Hotait, Athar Khalil, Fadi Bitar, Mariam Arabi, Samir Arnaout, Hadi Skouri, Antoine Abchee, Bernard Abi-Saleh, Maurice Khoury, Andreas Massouras, Georges Nemer   +14 more
doaj   +1 more source

Current Perspectives on Cardiomyopathies

, 2018
Advances in the understanding of cardiomyopathies and the growth of cardiology have paralleled one another. Over the years, many classification methods have been developed for cardiomyopathies based on aetiology, structural models and the functional ...

core   +1 more source

Analysis of effector/memory regulatory T cells from arrhythmogenic cardiomyopathy patients identified IL-32 as a novel player in ACM pathogenesis

Cell Death and Disease
Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiac disorder that causes sudden cardiac death and progressive heart failure. Besides fibro-fatty replacement and myocyte degenerative changes, inflammatory patchy infiltrates are found in myocardial
Salwa Soussi, Angela Serena Maione, Lise Lefèvre, Nathalie Pizzinat, Jason Iacovoni, Ignacio Gonzalez-Fuentes, Daniel Cussac, Lara Iengo, Yohan Santin, Fabrizio Tundo, Claudio Tondo, Giulio Pompilio, Angelo Parini, Victorine Douin-Echinard, Elena Sommariva   +14 more
doaj   +1 more source

Atrial remodelling and dysfunction in hypertrophic cardiomyopathy: prognostic role and therapeutic target

Frontiers in Cardiovascular Medicine
IntroductionHypertrophic cardiomyopathy (HCM) is a common genetic cardiac disease marked by abnormal ventricular hypertrophy. Recent studies have highlighted that left atrial (LA) remodelling—including dilation, fibrosis, and functional impairment—plays ...
Chiara Piazzai, Alessio Petrone, Andrea Stefanini, Flavio D’Ascenzi, Iacopo Olivotto, Iacopo Olivotto, Matteo Cameli   +6 more
doaj   +1 more source

Incidence of long-term cardiotoxicity and evolution of the systolic function in patients with breast cancer treated with anthracyclines

Cardiology Journal, 2022
BACKGROUND: Anthracycline cardiotoxicity (AC) may manifest years after treatment (long-term cardiotoxicity). There is little data on the incidence and natural history of AC in the current context, with protocols including lower anthracycline doses.
Rebeca Mata Caballero, José María Serrano Antolín, Rosa María Jiménez Hernández, Pedro Talavera Calle, Alejandro Curcio Ruigómez, Silvia del Castillo Arrojo, Catherine Graupner Abad, Carmen Cristóbal Varela, Joaquín Jesús Alonso Martín   +8 more
doaj   +1 more source

Classification of cardiomyopathies

, 2014
The AHA and ESC classifications of cardiomyopathies are presented.
Bernard J. Gersh, Demosthenes G. Katritsis, A. John Camm   +2 more
core   +1 more source